Bridging genomics research between developed and developing countries: The Genomic Medicine Alliance

Personalized Medicine

Volumn 11, Issue 7, 2014, Pages 615-623

  Cooper, David N ^a   Brand, Angela ^b   Dolzan, Vita ^c   Fortina, Paolo ^d   Innocenti, Federico ^e   Michael Lee, Ming Ta ^f   MacEk, Milan ^g   Al Mulla, Fahd ^h   Prainsack, Barbara ⁱ   Squassina, Alessio ^j   Vayena, Effy ^k   Vozikis, Athanassios ^l   Williams, Marc S ^m   Patrinos, George P ⁿ  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e University of North Carolina   (United States)

^f RIKEN Center for Integrative Medical Sciences   (Japan)

^g CHARLES UNIVERSITY   (Czech Republic)

^h KUWAIT UNIVERSITY   (Kuwait)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF CAGLIARI   (Italy)

^k UNIVERSITY OF ZURICH   (Switzerland)

^l UNIVERSITY OF PIRAEUS   (Greece)

^m GEISINGER HEALTH SYSTEM   (United States)

ⁿ UNIVERSITY OF PATRAS   (Greece)

more..

Author keywords

economic evaluation in genomic medicine; ethics in genomics; genethics; genetics education; genome informatics; genome literacy; genomic medicine; pharmacogenomics; public health genomics; whole genome sequencing

Indexed keywords

ARTICLE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENOMIC MEDICINE ALLIANCE; GENOMICS; HEALTH CARE ORGANIZATION; HEALTH ECONOMICS; HUMAN; MEDICAL EDUCATION; MEDICAL ETHICS; PHARMACOGENOMICS; PUBLIC HEALTH; SCIENTIFIC LITERATURE; SCIENTIST;

EID: 84909974485     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.14.59     Document Type: Article

References (46)

1. Manolio TA, Chisholm RL, Ozenberger B Implementing genomic medicine in the clinic: the future is here. Genet. Med. 15 (4), 258-267 (2013).
2. Kilpinen H, Barrett JC. How next-generation sequencing is transforming complex disease genetics. Trends Genet. 29 (1), 23-30 (2013).
3. Gullapalli RR, Lyons-Weiler M, Petrosko P, Dhir R, Becich MJ, LaFramboise WA. Clinical integration of next-generation sequencing technology. Clin. Lab. Med. 32 (4), 585-599 (2012).
4. Lazaridis KN, McAllister TM, Babovic-Vuksanovic D Implementing individualized medicine into the medical practice. Am. J. Med. Genet. C Semin. Med. Genet. 166 (1), 15-23 (2014).
5. European Alliance for Personalised Medicine. www.euapm.eu.
6. PerMed Coordination and Support Action (CSA). www.permed2020.eu.
7. European Personalised Medicine Association (EPEMED). www.epemed.org.
8. European Society of Predictive Medicine (EUSPM). www.euspm.org.
9. Personalized Medicine Coalition (PMC). www.personalizedmedicinecoalition.org.
10. South East Asian Pharmacogenomics Consortium (SEAPHARM). www.seapharm.pharmagtc.net/index.php/index.php.
11. Global Alliance for Genomics and Health. www.ga4gh.org.
12. International Cancer Genome Consortium. www.icgc.org.
13. Genomic Medicine Alliance. www.genomicmedicinealliance.org.
14. NIH Medline Plus. The promise and payoff of rare diseases research, from NIH Director Dr. Francis S. Collins. NIH MedlinePlus 6 (1), 2-3 (2011).
15. The Golden Helix Foundation. www.goldenhelix.org.
16. Patrinos GP, Al Aama J, Al Aqeel A Recommendations for genetic variation data capture in emerging and developing countries to ensure a comprehensive worldwide data collection. Hum. Mutat. 32 (1), 2-9 (2011).
17. van Baal S, Zlotogora J, Lagoumintzis G ETHNOS: a versatile electronic tool for the development and curation of national genetic databases. Hum. Genomics 4 (5), 361-368 (2010).
18. Papadopoulos P, Viennas E, Gkantouna V Developments in FINDbase worldwide database for clinically relevant genomic variation allele frequencies. Nucleic Acids Res. 42 (Database issue), D1020-D1026 (2014).
19. ETHNOS Databases. www.findbase.org/index.php/ethnos-databases.
20. Patrinos GP. National and ethnic mutation databases: recording populations genography. Hum. Mutat. 27 (9), 879-887 (2006).
21. RD-Connect. www.rd-connect.eu.
22. Thompson R, Johnston L, Taruscio D RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J. Gen. Intern. Med. 29 (Suppl. 3), S780-S787 (2014).
23. Euro-PGx project. www.goldenhelix.org/index.php/research/pharmacogenomics-in-europe.
24. Pharmacogenomics for Every Nation Initiative (PGENI). www.pgeni.org.
25. Potamias G, Lakiotaki K, Katsila T Deciphering next-generation pharmacogenomics: an information technology perspective. Open Biol. 4 (7), 140071 (2014).
26. Mizzi C, Mitropoulou C, Mitropoulos K Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics 15 (9), 1223-1234 (2014).
27. Burke W, Khoury MJ, Stewart A, Zimmern RL. The path from genome-based research to population health: development of an international public health genomics network. Genet. Med. 8 (7), 451-458 (2006).
28. Mai Y, Mitropoulou C, Papadopoulou XE Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Pers. Med. 11 (1), 15-26 (2014).
29. Mette L, Mitropoulos K, Vozikis A, Patrinos GP. Pharmacogenomics and public health: implementing populationalized medicine. Pharmacogenomics 13 (7), 803-813 (2012).
30. Reydon TA, Kampourakis K, Patrinos GP. Genetics, genomics and society: the responsibilities of scientists for science communication and education. Pers. Med. 9 (6), 633-643 (2012).
31. Demmer LA, Waggoner DJ. Professional medical education and genomics. Annu. Rev. Genomics Hum. Genet. 15, 507-516 (2014).
32. Vayena E, Gourna E, Streuli J, Hafen E, Prainsack B. Experiences of early users of direct-to-consumer genomics in Switzerland; an exploratory study. Public Health Genomics 15 (6), 352-362 (2012).
33. Vayena E, Ineichen C, Stupka E, Hafen E. Playing a part in research? University students attitudes to direct-to-consumer genomics. Public Health Genomics 17 (3), 158-168 (2014).
34. Squassina A, Severino G, Grech G, Fenech A, Borg J, Patrinos GP. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. Pharmacogenomics 13 (5), 525-528 (2012).
35. Mitropoulou C, Mai Y, van Schaik RH, Vozikis A, Patrinos GP. Stakeholder Analysis in Pharmacogenomics and Genomic Medicine in Greece. Public Health Genomics (2014) (In Press).
36. Kampourakis K, Vayena E, Mitropoulou C Next generation pharmacogenomics: key challenges ahead. EMBO Rep. 15 (5), 472-476 (2014).
37. Prainsack B, Vayena E. Beyond the clinic: direct-to-consumer genomic profiling services and pharmacogenomics. Pharmacogenomics 14 (4), 403-412 (2013).
38. Kricka LJ, Fortina P, Mai Y, Patrinos GP. Direct-access genetic testing: the view from Europe. Nat. Rev. Genet. 12 (10), 670 (2011).
39. Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, Cooper DN. Genetic tests obtainable through pharmacies: the good, the bad and the ugly. Hum. Genomics 7 (1), 17 (2013).
40. Payne K, Shabaruddin FH. Cost-effectiveness analysis in pharmacogenomics. Pharmacogenomics 11 (5), 643-646 (2010).
41. Deverka PA, Vernon J, McLeod HL. Economic opportunities and challenges for pharmacogenomics. Annu. Rev. Pharmacol. Toxicol. 50, 423-437 (2010).
42. Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health 16 (Suppl 6), S20-S26 (2013).
43. Genomic Medicine Centers Meeting VI: Global Leaders in Genomic Medicine. www.genome.gov/27555775.
44. Public Health Genomics. www.karger.com/Journal/Home/224224.
45. Patrinos GP, Brand A. Public health genomics joins forces with the genomic medicine alliance. Public Health Genomics 17 (3), 125-126 (2014).
46. The Golden Helix Summer Schools. www.summerschools.goldenhelix.org.